Drug Target Review – Issue 4 2018
Posted: 26 November 2018 | Drug Target Review | No comments yet
In this issue: Omics-informed drug target discovery in combating emerging infectious diseases, measuring intracellular ATP levels to access compound-mediated cellular toxicity, and turning organoids into physiologically relevant high-content assays for drug discovery.
In this issue:
- UNDER THE MICROSCOPE: Under the microscope: CROs and microplate reader requirements
BMG Labtech - APPLICATION NOTE: Automated cell transfection and reporter gene assays
Beckman Coulter - IN-DEPTH FOCUS: Screening
- ORGANOIDS: Beyond ‘simple’ biology – turning organoids, spheroids, and 3D tissue models into physiologically relevant high-content assays for drug discovery
Matthias Nees and Malin Åkerfelt, University of Turku, Finland - GPCR: New frontiers in G protein-coupled receptor drug discovery
Christopher J. Langmead, Monash Institute of Pharmaceutical Sciences (MIPS) - IN-DEPTH FOCUS: Hit-to-lead
- APPLICATION NOTE: Direct measurements of cellular metabolism for identification
of mitochondrial drug targets
Agilent - IN-DEPTH FOCUS: Targets
- PROTEOMICS: Proteomics: cracking the molecular mystery of diseases and therapeutics
Anowarul Amin, National Institutes of Neurological Disorders and Stroke (NINDS), NIH – Bethesda, MD - SUPPLEMENT: Application notes
With contributions from Eppendorf, IDBS, Intellicyt, Sciex and ThermoFisher Scientific.
Issue 4 of Drug Target Review is restricted - login or subscribe free to access
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related topics
Analytical techniques, Assays, Drug Targets, GPCRs, Hit-to-Lead, Organoids, Proteomics, Screening